Global Bladder Cancer Therapeutics Market Is Estimated To Witness Growth Due To Growing Prevalence Of Tumors And Increasing Innovations Of Drugs For Its Treatment

 

Bladder Cancer Therapeutics Market
Bladder Cancer Therapeutics Market 

Overview:

Bladder Cancer Therapeutics is an industry that offers therapies and products that treat the bladder. The primary aim of treatment is to prevent or slow the progression of the disease. It also helps to reduce mortality. Several treatment options are available, ranging from chemotherapy to immunotherapy. Immunotherapy is a form of cancer therapy that stimulates the body's immune system to fight cancer. This method has gained traction as an effective treatment for bladder cancer. Intravesical therapy is a form of immunotherapy that uses a drug that is injected into the bladder. This method can be used for stage II or III bladder cancers. Chemotherapy is another common method for treating bladder cancer. Chemotherapy is given by vein, whereas it can be drained into the bladder as well. Radiation therapy for bladder cancer is often combined with chemotherapy.

 

Market Dynamics:

Growing product approvals is anticipated to propel growth of the global bladder cancer therapeutics market over the forecast period. For instance, Merck KGaA and Pfizer declared that the PD-L1 inhibitor Bavencio has gained approval from the US FDA in January 2020. The positive data from the phase III studies have shown better results in patients suffering from metastatic urothelial cancer. Moreover, increasing costs of bladder cancer therapies is estimated to hinder growth of the global bladder cancer therapeutics market over the forecast period.


Impact of COVID-19:

The pandemic was first reported in 2019 and it had significant impact on many countries around the world. The outbreak of the virus directly affected the economy of many countries globally. It also affected the demand and production of various products. The pandemic had a huge impact on the healthcare sector. The healthcare sector was battling with COVID-19 and it was facing several challenges like shortage of medical equipment, skilled professionals and many more. The healthcare sector was more focusses on attending to COVID-19 patients, this led to delaying other treatments. This hampered the growth of the global bladder cancer therapeutics market. As many organizations and pharmaceuticals were focusing on developing vaccines and drugs for COVID-19. However, in the post-pandemic era the market is estimated to witness growth.


Key Takeaways:

The global bladder cancer therapeutics market is anticipated to witness significant growth, exhibiting CAGR of XX% over the forecast period, owing to growing research and developmental activities. For instance, a clinical study was launched by Nanostics Inc., in July 2022, for validating the ClarityDX Bladder, a minimally invasive bladder cancer diagnostic test. The test will be performed using the ClarityDX diagnostic platform.

North America is anticipated to witness significant growth in the global bladder cancer therapeutics market over the forecast period, due growing research and development activities and rising expenditure on healthcare in the region.

Major players operating in the global bladder cancer therapeutics market are Celgene Corporation, AstraZeneca, Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Endo Pharmaceuticals Inc., Lilly, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer Inc., GSK plc, and Novartis AG.


Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techn
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories of a
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C
Read more